Iqbal J, Gunn J, Serruys PW. Coronary stents: historical development, current status and future directions. Br Med Bull. 2013;106:193–211.

CAS  PubMed  Google Scholar 

Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–9.

CAS  PubMed  Google Scholar 

Shi N, Chen SY. Smooth muscle cell differentiation: model systems, regulatory mechanisms, and vascular diseases. J Cell Physiol. 2016;231:777–87.

CAS  PubMed  Google Scholar 

Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg. 2007;45:A25–A32.

PubMed  Google Scholar 

Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118:692–702.

CAS  PubMed  PubMed Central  Google Scholar 

Nishida-Aoki N, Tominaga N, Takeshita F, Sonoda H, Yoshioka Y, Ochiya T. Disruption of circulating extracellular vesicles as a novel therapeutic strategy against cancer metastasis. Mol Ther. 2017;25:181–91.

CAS  PubMed  PubMed Central  Google Scholar 

Jansen F, Nickenig G, Werner N. Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and epidemiology. Circ Res. 2017;120:1649–57.

CAS  PubMed  Google Scholar 

Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–83.

CAS  PubMed  PubMed Central  Google Scholar 

Wang Z, Zhu H, Shi H, Zhao H, Gao R, Weng X, et al. Exosomes derived from M1 macrophages aggravate neointimal hyperplasia following carotid artery injuries in mice through miR-222/CDKN1B/CDKN1C pathway. Cell Death Dis. 2019;10:422.

PubMed  PubMed Central  Google Scholar 

Vajen T, Benedikter BJ, Heinzmann ACA, Vasina EM, Henskens Y, Parsons M, et al. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. J Extracell Vesicles. 2017;6:1322454.

PubMed  PubMed Central  Google Scholar 

Sorrentino TA, Duong P, Bouchareychas L, Chen M, Chung A, Schaller MS, et al. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo. JVS Vasc Sci. 2020;1:28–41.

PubMed  PubMed Central  Google Scholar 

Johnsen KB, Gudbergsson JM, Andresen TL, Simonsen JB. What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer. Biochim Biophys Acta Rev Cancer. 2019;1871:109–16.

CAS  PubMed  Google Scholar 

Wang Y, Xie Y, Zhang A, Wang M, Fang Z, Zhang J. Exosomes: an emerging factor in atherosclerosis. Biomed Pharmacother. 2019;115:108951.

CAS  PubMed  Google Scholar 

Park M, Kim JW, Kim KM, Kang S, Kim W, Kim JK, et al. Circulating small extracellular vesicles activate TYRO3 to drive cancer metastasis and chemoresistance. Cancer Res. 2021;81:3539.

CAS  PubMed  Google Scholar 

Linger RMA, Keating AK, Earp HS, Graham DK. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res. 2008;100:35–83.

CAS  PubMed  PubMed Central  Google Scholar 

Melaragno MG, Fridell YWC, Berk BC. The Gas6/Axl system: a novel regulator of vascular cell function. Trends Cardiovasc Med. 1999;9:250–3.

CAS  PubMed  Google Scholar 

Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60:9–18.

CAS  PubMed  Google Scholar 

Yan X, Doffek K, Yin C, Krein M, Phillips M, Sugg SL, et al. Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo. Cancer Immunol Immunother. 2012;61:1917–27.

CAS  PubMed  Google Scholar 

Krahling S, Callahan MK, Williamson P, Schlegel RA. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 1999;6:183–9.

CAS  PubMed  Google Scholar 

Nakano T, Higashino K, Kikuchi N, Kishino J, Nomura K, Fujita H, et al. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca2+-mobilizing growth factors. J Biol Chem. 1995;270:5702–5.

CAS  PubMed  Google Scholar 

Kasikara C, Kumar S, Kimani S, Tsou W-I, Geng K, Davra V, et al. Phosphatidylserine sensing by TAM receptors regulates AKT-dependent chemoresistance and PD-L1 expression. Mol Cancer Res. 2017;15:753.

CAS  PubMed  PubMed Central  Google Scholar 

Goruppi S, Ruaro E, Varnum B, Schneider C. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol. 1997;17:4442–53.

CAS  PubMed  PubMed Central  Google Scholar 

Hu Y-L, Lu S, Szeto KW, Sun J, Wang Y, Lasheras JC, et al. FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells. Sci Rep. 2014;4:6024.

CAS  PubMed  PubMed Central  Google Scholar 

Linger RM, Cohen RA, Cummings CT, Sather S, Migdall-Wilson J, Middleton DH, et al. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene. 2013;32:3420–31.

CAS  PubMed  Google Scholar 

Ghiso E, Migliore C, Ciciriello V, Morando E, Petrelli A, Corso S, et al. YAP-dependent AXL overexpression mediates resistance to EGFR inhibitors in NSCLC. Neoplasia. 2017;19:1012–21.

CAS  PubMed  PubMed Central  Google Scholar 

Mudduluru G, Leupold JH, Stroebel P, Allgayer H. PMA up‐regulates the transcription of Axl by AP‐1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells. Biol Cell. 2011;103:21–33.

CAS  Google Scholar 

Lachowski D, Cortes E, Robinson B, Rice A, Rombouts K, Del Rio Hernandez AE. FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis. FASEB J. 2018;32:1099–107.

CAS  PubMed  Google Scholar 

Song X, Xu H, Wang P, Wang J, Affo S, Wang H, et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol. 2021;75:888–99.

CAS  PubMed  PubMed Central  Google Scholar 

Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 2001;293:306–11.

CAS  PubMed  Google Scholar 

Ye F, Li Q, Ke Y, Lu Q, Han L, Kaplan HJ, et al. TAM receptor knockout mice are susceptible to retinal autoimmune induction. Invest Ophthalmol Vis Sci. 2011;52:4239–46.

CAS  PubMed  PubMed Central  Google Scholar 

Togliatto G, Dentelli P, Rosso A, Lombardo G, Gili M, Gallo S, et al. PDGF-BB carried by endothelial cell–derived extracellular vesicles reduces vascular smooth muscle cell apoptosis in diabetes. Diabetes. 2018;67:704.

CAS  PubMed  Google Scholar 

Otani K, Yokoya M, Fujioka Y, Okada M, Yamawaki H. Small extracellular vesicles from rat plasma promote migration and proliferation of vascular smooth muscle cells. J Vet Med Sci. 2020;82:299–306.

CAS  PubMed  PubMed Central  Google Scholar 

McShane L, Tabas I, Lemke G, Kurowska-Stolarska M, Maffia P. TAM receptors in cardiovascular disease. Cardiovasc Res. 2019;115:1286–95.

CAS  PubMed  PubMed Central  Google Scholar 

Jin CW, Wang H, Chen YQ, Tang MX, Fan GQ, Wang ZH, et al. Gas6 delays senescence in vascular smooth muscle cells through the PI3K/ Akt/FoxO signaling pathway. Cell Physiol Biochem. 2015;35:1151–66.

CAS  PubMed  Google Scholar 

Korshunov Vyacheslav A. Axl-dependent signalling: a clinical update. Clin Sci. 2012;122:361.

CAS  Google Scholar 

Dagamajalu S, Rex DAB, Palollathil A, Shetty R, Bhat G, Cheung LWT, et al. A pathway map of AXL receptor-mediated signaling network. J Cell Commun Signal. 2021;15:143–8.

CAS  PubMed  Google Scholar 

Cummings CT, DeRyckere D, Earp HS, Graham DK. Molecular pathways: MERTK signaling in cancer. Clin Cancer Res. 2013;19:5275.

CAS  PubMed  Google Scholar 

Louis SF, Zahradka P. Vascular smooth muscle cell motility: from migration to invasion. Exp Clin Cardiol. 2010;15:e75–e85.

CAS  PubMed  PubMed Central  Google Scholar 

Jeong K, Kim J-H, Murphy JM, Park H, Kim S-J, Rodriguez YA, et al. Nuclear focal adhesion kinase controls vascular smooth muscle cell proliferation and neointimal hyperplasia through GATA4-mediated cyclin D1 transcription. Circ Res. 2019;125:152–66.

CAS  PubMed  PubMed Central  Google Scholar 

Melaragno MG, Wuthrich DA, Poppa V, Gill D, Lindner V, Berk BC, et al. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein–coupled receptor agonists in rats. Circ Res. 1998;83:697–704.

CAS  PubMed  Google Scholar 

Saab S, Chang OS, Nagaoka K, Hung MC, Yamaguchi H. The potential role of YAP in Axl-mediated resistance to EGFR tyrosine kinase inhibitors. Am J Cancer Res. 2019;9:2719–29.

CAS  PubMed  PubMed Central  Google Scholar 

Kimura TE, Duggirala A, Smith MC, White S, Sala-Newby GB, Newby AC, et al. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP. J Mol Cell Cardiol. 2016;90:1–10.

CAS